Quicksilver Therapeutics Private Limited
About Quicksilver Therapeutics Private Limited
Data last updated:
Quicksilver Therapeutics Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the real estate leasing and property management segment of the real estate sector. It was incorporated on 15 December 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U70109KA2020PTC142235.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10,000. It is led by directors Papraj Sudhakar and Jayalakshmi Muniswamappa.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at #392 8th B Main 4th Cross Viveknagar, Bangalore, Karnataka, India – 560047.
Company details
Contact details
Quicksilver Therapeutics Private Limited's registered office is in Bangalore, Karnataka.
- Registered Address#392 8th B Main 4th Cross Viveknagar, Bangalore, Karnataka, India – 560047
- IndustryReal Estate, Real Estate Leasing
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Quicksilver Therapeutics Private Limited
FY 2024 filings availableFinancial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ||||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ||||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | ||||
| Net Profit Margin | ||||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Quicksilver Therapeutics Private Limited, buy the company report.
Board of directors of Quicksilver Therapeutics Private Limited
Quicksilver Therapeutics has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Papraj Sudhakar | Director | 15 Dec 2020 | 5 Years 10 Months | Current |
| Jayalakshmi Muniswamappa | Director | 25 Sep 2021 | 5 Years 0 Months | Current |
Legal cases
No court or tribunal cases involving Quicksilver Therapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Quicksilver Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Quicksilver Therapeutics Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Quicksilver Therapeutics Private Limited has 4 board changes on record since 2020: 2 appointments and 2 cessations. The latest: Jayalakshmi Muniswamappa ceased to be Additional Director on 31 Dec 2021.
Frequently asked questions
Quicksilver Therapeutics is an active private limited company based in Bangalore, Karnataka, India. The company works in real estate leasing, within the real estate industry. It was incorporated on 15 December 2020 (6+ years old) and is registered under CIN U70109KA2020PTC142235.
Quicksilver Therapeutics has 2 current directors:
- Papraj Sudhakar - Director
- Jayalakshmi Muniswamappa - Director
The latest financial statements of Quicksilver Therapeutics on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Quicksilver Therapeutics is U70109KA2020PTC142235. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Quicksilver Therapeutics was incorporated on 15 December 2020, making it 6+ years old. It is registered with the Registrar of Companies, Bangalore.
Jayalakshmi Muniswamappa ceased to be Additional Director on 31 Dec 2021. Coimbatore Laxman Subramanyam ceased to be Director on 25 Sep 2021. Jayalakshmi Muniswamappa was appointed as Director on 25 Sep 2021. Quicksilver Therapeutics has 4 board changes on record in total.
The registered office of Quicksilver Therapeutics is at #392 8th B Main 4th Cross Viveknagar, Bangalore, Karnataka, India – 560047.
Quicksilver Therapeutics operates in the real estate industry, in the real estate leasing segment.
Quicksilver Therapeutics can be reached at its registered office: #392 8th B Main 4th Cross Viveknagar, Bangalore, Karnataka, India – 560047.
Quicksilver Therapeutics is registered under the jurisdiction of the Registrar of Companies (ROC), Bangalore.